HRTS250516C34000
- 0.00
- 0.000.00%
Tema GLP-1, Obesity & Cardiometabolic ETF Newsroom
Earnings Week Ahead: MSFT, AAPL, META, AMZN, QCOM, PFE, MA, V, PYPL, ROKU, MCD, SBUX, KO, and More
Executive Reshuffles: NNDM, BSX, and APPN
$1000 Invested In This Stock 20 Years Ago Would Be Worth This Much Today
Eli Lilly Seeks a Review of EU Rejection of Alzheimer's Therapy
How Is The Market Feeling About Gilead Sciences?
SA Analyst Downgrades: T, DOW, SMCI, UNH
About 75% of the Names That Reported Earnings This Week Delivered EPS Wins: Earnings Scorecard
Check Out What Whales Are Doing With UNH
UnitedHealth Group Shares Are Trading Lower After Barclays Cut Its Price Target on the Stock From $560 to $513.
4 Stocks to Watch on Friday: GILD, ABBV, CL and SLB
Needham Reiterates Hold on Gilead Sciencesto Hold
Gilead Sciences Analyst Ratings
Skechers Posts Weak Revenue, Joins Intel, Gilead Sciences And Other Big Stocks Moving Lower In Friday's Pre-Market Session
Ozempic Compounders Suffer Fresh Setback as Judge Rejects Injunction
Why Coursera Shares Are Trading Higher By Over 7%; Here Are 20 Stocks Moving Premarket
Alphabet, Intel And 3 Stocks To Watch Heading Into Friday
Genentech's Xofluza Demonstrates 32% Reduction In Household Transmission Of Influenza In Global Phase III Trial
Gilead Sciences Declares $0.79 Dividend
The company's CEO has clearly stated: the trade war will destroy everything!
Due to the cost surge brought about by Trump's tariff policy and the wavering of Consumer confidence, many corporate giants in the USA have significantly lowered their earnings expectations during this earnings report season, covering various fields such as Consumer goods, Aviation, Energy, and telecommunications. Statistics show that more than 90% of companies mentioned the impact of tariffs during their earnings call, with the mention rate of the term 'recession' soaring from less than 3% in the fourth quarter of last year to 44%.
Earnings Call Summary | Gilead Sciences(GILD.US) Q1 2025 Earnings Conference